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Abstract 
 
Background:  
Selective Digestive Decontamination involves the routine administration of oral, 
gastric, and intravenous antibiotics to mechanically ventilated children to prevent 
hospital-acquired infections. It has a strong evidence base in adults, with limited 
pediatric data. Knowledge of the practice among pediatric providers in North 
America is unknown.  
 
Methods:  
This is an electronic survey administered to pediatric critical care and pediatric 
infectious disease providers in Canada. Questions were asked regarding current 
institutional practice, their current knowledge regarding the evidence, and 
perceptions as to its risks and benefits.  Descriptive statistics were analyzed.  
 
Results:  
The overall survey response rate was 33%, for a total of 47 responses. No hospital in 
Canada routinely performs SDD and the majority of respondents (73.9%) have 
neutral opinions on the subject. There was concern for increasing antibiotic 
resistance (43.1%) and some disagreement with the intravenous component of SDD 
(47%). The majority of respondents stated a need for pediatric-specific data before 
integrating SDD into their practice, even if further, large adult RCTs were performed.   
 
 
Conclusion: 
Among Canadian providers, there is minimal knowledge or use of selective digestive 
decontamination as a tool for preventing hospital-acquired infections. Before 
further interventional studies are performed, there is a need for educational 
interventions to assess readiness and acceptability of the intervention.  
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Background 1 
Hospital-acquired infections remain a major contributor to morbidity and mortality 2 
among critically ill children around the world.[1-4] The costs of these infections are 3 
large, and estimated costs are over 40,000 dollars to hospital charges among 4 
critically ill children in the United States, for example.[5] The microbiologic etiology 5 
of many of these infections are commensal or opportunistic organisms that live in 6 
the oropharynx and upper digestive tract, often causing infection-related ventilator-7 
associated complications or translocating across mucosal layers to cause 8 
bloodstream infections.[6, 7]  9 
 10 
Evidence-based recommendations to prevent these infections typically involve 11 
removing the foreign material at the earliest possible opportunity and ensuring that 12 
bacterial entry into lungs or blood is minimized.[8, 9] Decontamination of these 13 
opportunistic organisms through administration of specific antibiotics has been 14 
extensively studied in adult populations, with a sizable benefit documented in 15 
mortality among critically ill adults.[10-13]However, the use of these 16 
decontamination protocols has been limited, even within adult critical care units, 17 
primarily due to concerns among clinicians about fomenting further antibiotic 18 
resistance, as well as side-effects of antibiotic administration. [14, 15] 19 
 20 
In children, there is evidence, primarily generated from areas of Europe, that 21 
selective digestive decontamination reduces the incidence of hospital-acquired 22 
pneumonia.[16] Determining the baseline knowledge of providers in a jurisdiction 23 
that has not traditionally performed digestive decontamination is crucial before 24 
determining whether further study is warranted in the critically ill child.  25 
 26 
Methods 27 
Study setting: Between May and July 2016, a national survey was conducted among 28 
Canadian pediatric ID and critical care specialists regarding their knowledge 29 
surrounding selective digestive decontamination (SDD) in critically ill children. 30 
Approval for the survey was granted by the research ethics board at BC Children’s 31 
Hospital and the University of British Columbia (Vancouver, Canada).  32 
Survey Design: The survey consisted of 16 short questions regarding SDD, including 33 
understanding their current institutional practice, their current knowledge 34 
regarding the evidence, and perceptions as to its risks and benefits. Further, 35 
questions were asked to ascertain comfort with performing a trial and in 36 
incorporating evidence from data generated in adult patients into pediatric practice. 37 
The survey was adapted from a validated instrument used in adults, as part of the 38 
SUDDICU program of research.[14] The adapted version was pilot tested on 5 39 
specialists to determine ease of use and time required, and no major changes were 40 
made to the survey during this process.[17] 41 
Survey Administration: The survey was anonymous, confidential and self-42 
administered by clinicians via REDCAP[18] through two separate electronic mail-43 
outs. Pediatric infectious diseases specialists were identified through being on-staff 44 
at the academic teaching hospitals in Canada (n=57), and pediatric critical care 45 
 5 
specialists were identified through prior survey lists generated through the 1 
Canadian Critical Care Trials Group (n=115).  2 
Statistical Analysis: A descriptive analysis of familiarity with SDD included reporting 3 
summary statistics and graphical displays of the distribution of responses. 4 
Univariate statistical tests were performed across groups by years in practice and 5 
specialty.  6 
 7 
Results 8 
From the 172 individuals on the two electronic lists, 143 email addresses were 9 
valid; of these, 47 responded to the survey, for a response rate of 33%. This low 10 
response rate was attributed to the summer months, as well as a global 11 
unfamiliarity with the concept of SDD. Of the 47 respondents, 39 identified as 12 
critical care physicians, 7 as infectious disease physicians, and 1 as an infection 13 
control specialist. The years in practice varied, with 36% having between 5 and 10 14 
years experience, 25% having between 10 and 20, and 30% having more than 20 15 
years clinical experience. 16 
 17 
No individual in Canada reported delivering SDD routinely to critically ill children, 18 
with only one individual claiming to deliver SDD in a non-protocolized fashion. The 19 
majority of respondents (63.8%) claimed to have below-neutral knowledge of the 20 
evidence base for SDD, and to have a neutral opinion (73.9%) regarding its use. 47% 21 
of respondents were somewhat or strongly opposed to the intravenous component 22 
of SDD and 40.4% thought that using SDD increased antibiotic resistance.  A small 23 
number of individuals felt that SDD reduced the incidence of VAP (34%). 24 
 25 
The majority of individuals had neutral opinions on the risk-benefit profile of SDD 26 
(67%), that it benefited the patients to whom it was delivered (77.3%), and that it 27 
reduced mortality (76.1%).  28 
 29 
In the absence of further pediatric-specific trial data, evidence from adult 30 
randomized trials that documented a 3.5% reduction in mortality would convince 31 
only 34% of respondents to incorporate SDD into their pediatric practice. In the 32 
absence of further adult randomized evidence, 60% of respondents think that 33 
performing randomized trials in children is reasonable. 62% of respondents think 34 
that the results of SDD will be very different in children than in adults.  35 
 36 
There was no statistically significant difference in responses by years spent in 37 
practice or primary area of practice.  38 
 39 
Discussion 40 
In this survey of Canadian providers, selective digestive decontamination was not 41 
performed, and very little knowledge of the evidence base was apparent. There was 42 
ongoing concern for spreading antibiotic resistance, although many wanted a 43 
pediatric-specific study to be performed, thinking that the results in a pediatric 44 
study will be very different than those in adult studies.  45 
 46 
 6 
These results are unsurprising, given the complicated history of SDD around the 1 
world. Despite fairly high-level evidence, its practice has not been disseminated 2 
outside of certain jurisdictions for a variety of reasons, including conflicting 3 
evidence of benefit in the adult literature, concerns for antibiotic resistance, and 4 
lack of pediatric-specific evidence.[19-21] Because of this, knowledge surrounding 5 
SDD is limited, especially among pediatric providers. 6 
  7 
Incorporating adult-based evidence into pediatric practice is a controversial subject. 8 
[22, 23] Pediatric populations are likely to be different than adult populations in 9 
their response to SDD. The different flora present in the digestive tracts in children, 10 
especially neonates, compared with adults will likely impact the effects of any 11 
digestive decontamination protocols.. The incidence of VAP and mortality in 12 
critically ill children is much lower than in adults, altering any outcome analysis. 13 
Further, the numbers of critically ill children who are mechanically ventilated for 2 14 
or more days are small, making sample size estimates for a large trial 15 
prohibitive.[16]  16 
 17 
The limitations of this study are few. First, the response rate was relatively low for a 18 
survey of this sort, especially among infectious disease physicians; responses among 19 
intensive care clinicians were much higher, perhaps more reflective of the nature of 20 
the intervention. Second, this survey captured only opinions, and did not perform 21 
in-depth interviews with subjects regarding their knowledge surrounding SDD. This 22 
was performed due to practicality, as well as presuming a very minimal level of 23 
knowledge surrounding SDD among pediatric providers.  24 
 25 
Conclusion 26 
Among pediatric providers in Canada, there was very limited knowledge 27 
surrounding selective digestive decontamination, with no institution currently 28 
performing it routinely.  Most providers would want pediatric-specific data before 29 
implementing SDD into their practice. Further research to determine the optimal 30 
outcome for such studies, including antibiotic resistance profiles, are warranted.  31 
 32 
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Figure 1: Views about Selective Digestive Decontamination among Canadian 5 
providers 6 
 7 
0
5
10
15
20
25
30
35
40
Strongly
Disagree
2 3 Neutral 5 6 Strongly
Agree
%
 o
f 
re
sp
o
n
d
e
n
ts
 
I am opposed to SDD 
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The effects of SDD will be very different in 
children than in adults 
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If a large, multi-center RCT was performed in 
adults documenting a 3.5% reduction in 
hospital mortality for mechanically ventilated 
adults without an increase in antibiotic 
resistance, I would adopt SDD into my pediatric 
setting 
